A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanism
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Pharmaceuticals, controlled release
2. Fundamental concepts of controlled release
3. Polymeric delivery systems for controlled drug release10.1080/00986448008912519 ↗
4. Controlled release: mechanisms and rates
5. Drug pacemakers in the treatment of heart block10.1111/j.1749-6632.1964.tb53154.x ↗
6. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel10.1016/0010-7824(85)90064-2 ↗
7. Norplant: reversible implant contraception10.2307/1966240 ↗
8. Polymers for the sustained release of proteins and other macromolecules10.1038/263797a0 ↗
9. Dialysis studies. III. Modification of pore size and shape in cellophane membranes10.1021/j100819a048 ↗
10. Hydrogels for controlled drug delivery10.1016/0142-9612(84)90063-2 ↗
11. Controlled release of macromolecules
12. Zero-order controlled-release polymer matrices for micro- and macromolecules10.1002/jps.2600720105 ↗
13. Polymers for sustained macromolecule release: procedure to fabricate reproducible delivery systems and control release kinetics10.1002/jps.2600690305 ↗
14. Long-term and constant release of vasopressin from Accurel tubing: implantation in the Brattleboro rat10.1677/joe.0.0980147 ↗
15. Controlled long-term release of small peptide hormones using a new microporous polypropylene polymer: its application for vasopressin in the Brattleboro rat and potential perinatal use10.1002/jps.2600731213 ↗
16. Mikroporöse Polymere
17. Versatile microporous polymers developed
18. The use of [3H] vasopressin for in vivo studies of controlled delivery from an Accurel/collodion device in the Brattleboro rat10.1111/j.2042-7158.1986.tb03378.x ↗
19. Effects of continuous administration of oxytocin by an Accurel device on parturition in the rat and on development and diuresis in the offspring10.1677/joe.0.1010121 ↗
20. Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy
21. Body and brain growth following continuous perinatal administration of arginine- and lysine-vasopressin to the homozygous Brattleboro rat10.1016/0165-3806(85)90178-6 ↗
22. Vasopressin fails to restore postnatally the stunted brain development in the Brattleboro rat, but affects water metabolism permanently
23. Vasopressin and vasopressin-antagonist applied to neonatal Wistar rats: effects on body and brain development and water metabolism
24. Successful ventricular application of the miniaturized controlled-delivery Accurel technique for sustained enhancement of cerebro-spinal fluid peptide levels in the rat10.1016/0165-0270(84)90090-6 ↗
25. Manipulation of vasopressin level in the cerebrospinal fluid of the rat by means of an easily interchangeable controlled-delivery Accurel mini-device10.1016/0165-0270(86)90063-4 ↗
26. Immunocytochemically stained binding sites for oxytocin and alpha-melanocyte-stimulating hormone in rat brain following ventricular administration10.1016/0006-8993(86)90800-0 ↗
27. Immunocytochemically-stained vasopressin binding sites in rat brain — ventricular application of vasopressin/Accurel in the Brattleboro rat10.1016/0022-510X(86)90178-4 ↗
28. Vasopressin in cerebrospinal fluid and plasma of man, dog and rat
29. Antibody-coated plastic tubes in radioimmunoassay
30. High-performance of liquid chromatography as a technique to measure the competitive adsorption of plasma protein onto lattices10.1016/0021-9797(84)90079-1 ↗
31. Affinity spectra: a novel way for the evaluation of equilibrium binding experiments10.1007/BF00500763 ↗
32. Proteins at interfaces
33. Dynamics of interactions between human albumin and polyethylene surface10.1016/0021-9797(78)90101-7 ↗
34. The interaction of plasma proteins with polymers. I. Relationship between polymer surface energy and protein adsorption/desorption10.1002/jbm.820140406 ↗
35. Studies of protein adsorption on polystyrene latex surfaces10.1016/0021-9797(80)90325-2 ↗
36. Estimation of the: permeability of cellulosic membranes from solute dimensions and diffusivities10.1002/jbm.820070403 ↗
37. Conformations of oxytocin and lysine-vasopressin and their relationships to the biology of neurohypophyseal hormones
38. Interaction of high molecular weight kininogen, factor XII and fibrinogen in plasma at interfaces10.1182/blood.V55.1.156.156 ↗
39. Restricted transport in small pores: a model for steric exclusion and hindered particle motion10.1016/S0006-3495(74)70005-4 ↗
40. Linear drug release from laminated hydroxypropyl-cellulose-polyvinyl acetate films10.1002/jps.2600640806 ↗
41. Membrane systems
42. Effect of nonionic surfactants on the transport of testosterone across a cellulose acetate membrane10.1002/jps.2600590716 ↗
43. Diffusion in polymer gel implants
44. The kinetics of protein adsorption on synthetics and modified natural surfaces10.1016/0021-9797(82)90098-4 ↗
45. In vivo and in vitro release of macromolecules from polymeric drug delivery systems10.1002/jps.2600721019 ↗
46. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules10.1002/jps.2600731258 ↗
47. Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin-antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in rats10.1016/0006-8993(87)90570-1 ↗
48. Hydrogels as drug delivery systems
49. One month of sustained release of insulin from a polymer implant10.2337/diab.29.1.37 ↗